Quantumscape Corp SEC Filings

QuantumScape (QS) shareholder filed a Form 144 notice to sell up to 220,000 shares of common stock with an aggregate market value of $3,318,844.98. The planned sale is listed with Morgan Stanley Smith Barney LLC and names the NYSE as the exchange, with an approximate sale date of 10/24/2025.

The filing lists how the shares were acquired, including multiple restricted stock vestings under a registered plan on dates across 2022–2024, and an option exercise on 10/24/2025 for 62,975 shares. As context, shares outstanding were 522,939,205 at the time cited in the notice.

QuantumScape (QS): A holder filed a Form 144 notice for a proposed sale of 400,000 common shares. The filing lists Morgan Stanley Smith Barney LLC as broker, an aggregate market value of $6,299,270, and an approximate sale date of 10/24/2025 on the NYSE.

The shares to be sold were acquired on 10/24/2025 through an exercise of options under a registered plan, from the issuer, with “Not Applicable” noted for the nature of payment. A Form 144 is a notice of intent to sell restricted or control securities under Rule 144; actual sales depend on market conditions and Rule 144 limits.

QuantumScape (QS) filed its Q3 2025 10-Q, reporting continued R&D-driven losses while strengthening liquidity. Net loss was $105.8 million (basic and diluted loss per share $0.18) on operating expenses of $115.0 million, down from $130.2 million a year ago as R&D and G&A declined.

Cash and cash equivalents were $225.8 million and marketable securities were $777.9 million as of September 30, 2025. Year-to-date operating cash outflow was $186.3 million. The company completed its at-the-market program, selling 29.3 million shares in the quarter for $263.3 million in net proceeds, bolstering capital for development.

QS recorded an $8.3 million lease termination loss (including $7.6 million impairment) and $9.5 million of fixed-asset write-offs in the quarter. A July amendment with PowerCo SE provides for up to $130.7 million of project funding over two years, subject to milestones; payments will be recorded as a liability and reclassified to equity upon extinguishment. The company remains pre-revenue and focused on scaling its QSE-5 solid-state battery program.

QuantumScape (QS) insider Michael McCarthy filed a Form 144 indicating a proposed sale of 46,264 common shares through Morgan Stanley Smith Barney LLC Executive Financial Services, with an aggregate market value of $706,042.29. The shares are listed on the NYSE, with an approximate sale date of 10/24/2025.

The notice details recent acquisitions under company plans: 25,000 from option exercises on 10/24/2025, 20,000 from restricted stock vesting on 05/15/2025, and 1,264 shares via the employee stock purchase plan across 06/02/2025 and 12/02/2024. It also lists prior sales in the last three months: 500,000 shares on 07/25/2025 for $5,798,840.00 and 38,035 shares on 09/12/2025 for $347,267.16. Shares outstanding were 522,939,205.

QuantumScape Corporation reported that it announced its business and financial results for the third quarter of 2025, which ended September 30. The company furnished a Q3 Fiscal 2025 Shareholder Letter as Exhibit 99.1 and a press release as Exhibit 99.2. These materials were provided under Item 2.02 of the 8-K and are treated as “furnished,” not “filed,” and are not incorporated by reference unless expressly stated.

The filing also lists the company’s Class A common stock (ticker QS) on the New York Stock Exchange and includes the required cover page interactive data file.

Timothy Holme, Chief Technology Officer of QuantumScape Corp (QS), reported transactions on 10/03/2025. The filing shows conversions and sales: conversions (Code C) of 108,655 and 44,923 shares of Class B into Class A common stock, and sales (Code S) of 166,442 and 44,923 shares pursuant to a Rule 10b5-1 trading plan adopted June 5, 2025. The reported weighted-average sale price was $15.5186, with sale prices ranging from $14.26 to $16.485. After the transactions the reporting person held 1,364,273 shares directly and reported 8,360,459 underlying Class A shares from converted Class B shares.

QuantumScape (QS) director reported insider transactions on 10/01/2025 under a Rule 10b5-1 plan adopted on June 13, 2025. The filing shows an option exercise (code M) of 130,065 Class A shares at $2.377 per share, followed by an open-market sale (code S) of 157,171 shares at a $13.9371 weighted-average price, with trades ranging from $12.09 to $14.805.

After these transactions, the reporting person beneficially owned 321,040 Class A shares directly, which includes 48,192 RSUs. Derivative holdings reported totaled 260,130 stock options outstanding (exercise price $2.377, expiring 12/11/2029).

Form 144 notice for QuantumScape Corp (QS): An individual insider, Kevin Hettrich, notified the SEC of a proposed sale of 9,800 shares of QuantumScape common stock through Goldman Sachs & Co. LLC on the New York Stock Exchange. The filing shows the 9,800 shares have an aggregate market value of $142,982 against approximately 522,939,205 shares outstanding, representing a de minimis fraction of the company. All 9,800 shares were acquired as restricted stock units issued by the company in 2023 and 2024 (four grant dates totaling 9,800 shares). The filer reported a prior sale of the same 9,800 shares on 09/12/2025 with gross proceeds of $90,177.64. The notice includes the signer’s representation that no undisclosed material adverse information is known.

Form 144 filed for QuantumScape Corp (QS) reporting proposed insider sales. Jeffrey B. Straubel notified a broker he intends to sell 157,171 shares of Class A common stock through Goldman Sachs with an approximate aggregate market value of $2,293,124.89 and an approximate sale date of 10/01/2025 on the NYSE. The filing shows 130,065 of the shares were acquired 12/11/2019 as compensation (stock options exercised cashless/same-day sale) and 27,106 were acquired 11/25/2020 as restricted stock units. The notice discloses two prior sales on 09/12/2025 totaling 157,180 shares with gross proceeds of $1,445,014.11 and affirms no undisclosed material adverse information by the seller.